Anti-tumor  	Anti-tumor  	 JJ	B-NP
necrosis  	necrosis  	 JJ	I-NP
factor  	factor  	 NN	I-NP
therapies  	therapies  	 NNS	I-NP
in  	in  	 IN	O
immune-mediated  	immune-mediated  	 JJ	O
rheumatic  	rheumatic  	 JJ	B-NP
diseases 	diseases 	 NNS	I-NP
.  	.  	 .	O
Other  	Other  	 JJ	O
observations  	observations  	 NNS	O
from  	from  	 IN	O
the  	the  	 DT	O
clinic  	clinic  	 NN	O
To  	To  	 TO	O
date 	date 	 NN	O
,  	,  	 ,	O
over  	over  	 IN	O
2  	2  	 CD	O
million  	million  	 CD	O
patients  	patients  	 NNS	O
worldwide  	worldwide  	 NNS	O
have  	have  	 VBP	O
been  	been  	 VBN	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
anti-tumor  	anti-tumor  	 JJ	B-NP
necrosis  	necrosis  	 JJ	I-NP
factor  	factor  	 NN	I-NP
( 	( 	 -LRB-	O
TNF 	TNF 	 NNP	B-NP
)  	)  	 -RRB-	O
therapies 	therapies 	 NNS	O
,  	,  	 ,	O
dramatically  	dramatically  	 RB	O
improving  	improving  	 VBG	O
the  	the  	 DT	O
treatment  	treatment  	 NN	B-NP
outcomes  	outcomes  	 NNS	I-NP
of  	of  	 IN	O
immune-mediated  	immune-mediated  	 JJ	B-NP
inflammatory  	inflammatory  	 JJ	I-NP
diseases  	diseases  	 NNS	I-NP
( 	( 	 -LRB-	O
IMID 	IMID 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Observations  	Observations  	 NNS	B-NP
from  	from  	 IN	O
clinicians  	clinicians  	 NNS	B-NP
have  	have  	 VBP	O
identified  	identified  	 VBN	O
some  	some  	 DT	O
curious  	curious  	 JJ	O
disconnects  	disconnects  	 NN	O
between  	between  	 IN	O
clinical  	clinical  	 JJ	O
and  	and  	 CC	O
radiographic  	radiographic  	 JJ	B-NP
outcomes 	outcomes 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
paradoxical  	paradoxical  	 JJ	B-NP
occurrence  	occurrence  	 NN	I-NP
of  	of  	 IN	I-NP
anti-TNF  	anti-TNF  	 NNP	I-NP
therapy-induced  	therapy-induced  	 NNP	I-NP
IMID  	IMID  	 NNP	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
psoriasis  	psoriasis  	 NN	B-NP
or  	or  	 CC	O
reactivation  	reactivation  	 NN	B-NP
of  	of  	 IN	I-NP
uveitis  	uveitis  	 NN	I-NP
and  	and  	 CC	O
Crohn 	Crohn 	 NNP	O
's  	's  	 POS	O
disease 	disease 	 NN	O
.  	.  	 .	O
These  	These  	 DT	O
observations  	observations  	 JJ	B-NP
point  	point  	 NN	O
to  	to  	 TO	O
the  	the  	 DT	O
need  	need  	 NN	O
for  	for  	 IN	O
a  	a  	 DT	O
better  	better  	 JJR	O
understanding  	understanding  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
mechanisms  	mechanisms  	 NNS	O
underlying  	underlying  	 VBG	O
the  	the  	 DT	O
ability  	ability  	 NN	B-NP
of  	of  	 IN	I-NP
anti-TNF  	anti-TNF  	 JJ	I-NP
therapies  	therapies  	 NNS	I-NP
to  	to  	 TO	O
reduce  	reduce  	 VB	O
inflammation  	inflammation  	 NNS	B-NP
and  	and  	 CC	O
how  	how  	 WRB	O
this  	this  	 DT	O
is  	is  	 VBZ	O
linked  	linked  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
pathogenesis  	pathogenesis  	 NN	B-NP
of  	of  	 IN	I-NP
IMID 	IMID 	 NNP	I-NP
.  	.  	 .	O
